Videos: Type 1 diabetes technology explained
Type 1 diabetes (T1D) technology is advancing as researchers make breakthroughs in treatment and management. Whether you’re new to the world of T1D, or just want to learn more about how the newest tech devices work, we have resources to help you understand it all.
Our friends at JDRF UK have created four explainer videos on four different types of T1D tech devices:
- continuous glucose monitors (CGMs)
- flash glucose sensors (also known as flash glucose monitoring, or flash GM)
- insulin pumps
- hybrid closed-loop technology (also known as automated insulin delivery (AID), or the artificial pancreas).
Watch the short clips below, then find links to more information to help you learn more about each type of T1D device.
What is continuous glucose monitoring?
This 90 second video explains how continuous glucose monitors (CGMs) work, and how they can help manage blood glucose levels in people who live with type 1 diabetes.
Read more about continuous glucose monitors and the CGM Initiative.
What are flash glucose monitors (or sensors)?
Watch this two-minute video to learn how flash glucose monitoring can help manage glucose levels.
Learn more about flash glucose monitors or read the NDSS factsheet.
What does an insulin pump do?
This 90-second video explains how an insulin pump works, and how it can help you (or your child) manage T1D.
Learn more about insulin pumps and the Insulin Pump Program.
What is hybrid closed-loop technology (or the artificial pancreas)?
Watch this two-and-a-half minute video to learn what hybrid closed loop technology is, and how it can help reduce the impact of type 1 diabetes management.
Learn more about hybrid closed-loop technology.
JDRF welcomes decision to extend availability of Fiasp on the PBS
MEDIA RELEASE JDRF Australia welcomes Government’s decision to extend availability of Fiasp insulin on the Pharmaceutical Benefits Scheme The move will keep the life-saving medication in the hands of the 15,000+ people who rely on it for a further six months Sydney, 17 March 2023: JDRF Australia is today welcoming an announcement by the Albanese […]
Your child’s return to school after a type 1 diabetes diagnosis
The days, weeks and months following your child’s type 1 diabetes (T1D) diagnosis are full of firsts. And one of the biggest milestones your family will work towards is your child’s first day back at preschool or school. You’ll no doubt be feeling uncertain and will have many questions in the lead up to their […]
Dr. Ki Wook Kim On Developing Vaccines To Prevent Type 1 Diabetes
“The ultimate goal is to help develop vaccines to prevent T1D, as well as antiviral therapeutics to potentially treat people already diagnosed with T1D” Dr Kim’s work aims to uncover the link between viruses and type 1 diabetes (T1D). As one of the lead investigators of ENDIA, Dr Kim is looking at whether early infection […]
Scheduled removal of Fiasp from the Pharmaceutical Benefits Scheme
JDRF Australia are aware that Fiasp insulin is currently scheduled for removal from the Pharmaceutical Benefits Scheme from 1 April 2023. If removed at this date, it will no longer be available at a subsidised cost however will reportedly be available privately for a period of time. This is a significant concern to us and for many […]